| Beclometasone |
№ 6763/26.01.2010 |
Ecobec 100 MCG Easi-Breathe, Pressurised inhalation, solution, 100 mcg/dose - 200 doses, mcg, Pack: 1 |
Teva Czech Industries s.r.o., Чешка република |
Teva Czech Industries s.r.o. Chech Republic |
21.67 |
4.33 |
26 |
6% |
1.3 |
22.97 |
4.59 |
27.56 |
18% |
3.9 |
26.87 |
5.37 |
32.24 |
КЦ-2303/10.06.2011 промяна на обстоятелства |
КЦ-700/09.03.2009 |
24.03.2009 |
24.03.2009 |
Неактивен |
3123 |
| Beclometasone |
20030347 |
Ecobec 250 MCG Easi-Breathe, Pressurised inhalation, solution, 250 mcg/dose - 200 doses, mcg, Pack: 1 |
Teva Czech Industries s.r.o., Чешка република |
Teva Czech Industries s.r.o. Chech Republic; Norton Waterford (IVAX Pharmaceuticals Ireland), Waterford, Ирландия |
29.32 |
5.86 |
35.18 |
6% |
1.76 |
31.08 |
6.22 |
37.3 |
18% |
5.28 |
36.36 |
7.27 |
43.63 |
промяна в обстоятелства НСР-5346/18.12.2014; промяна в обстоятелства НСР-5711/18.02.2015; Цената е заличена с решение НСР-7130/24.09.2015 ( в сила от 16.10.2015 ) |
НСР-5072/21.11.2014 |
08.12.2014 |
08.12.2014 |
Заличен |
3354 |
| Beclometasone |
№ 6764/26.01.2010 |
Ecobec 250 MCG Easi-Breathe, Pressurised inhalation, solution, 250 mcg/dose - 200 doses, mcg, Pack: 1 |
Teva Czech Industries s.r.o., Чешка република |
Teva Czech Industries s.r.o. Chech Republic |
29.75 |
5.95 |
35.7 |
6% |
1.79 |
31.54 |
6.31 |
37.85 |
18% |
5.36 |
36.9 |
7.38 |
44.28 |
КЦ-2303/10.06.2011 промяна на обстоятелства |
КЦ-700/09.03.2009 |
24.03.2009 |
24.03.2009 |
Неактивен |
3354 |
| Salbutamol |
20010556 |
Ecosal Easi-Breathe, Pressurised inhalation, suspension, 0,1 mg/dose - 200 doses, mg, Pack: 1 |
Teva Czech Industries s.r.o., Чешка република |
Teva Czech Industries s.r.o., Czech Republic; Norton Waterford (IVAX Pharmaceuticals Ireland) - Ireland |
5.07 |
1.01 |
6.08 |
7% |
0.35 |
5.42 |
1.08 |
6.5 |
20% |
1.01 |
6.43 |
1.29 |
7.72 |
Протокол 191/29.09.2016 |
НСР-5962/01.04.2015.; НСР-12237/03.04.2017 |
16.04.2015 |
02.05.2017 |
Заличен |
3785 |
| Salbutamol |
20010556 |
Ecosal Easi-Breathe, Pressurised inhalation, suspension, 0,1 mg/dose - 200 doses, mg, Pack: 1 |
Teva Czech Industries s.r.o., Чешка република |
Teva Czech Industries s.r.o., Czech Republic; Norton Waterford (IVAX Pharmaceuticals Ireland) - Ireland |
5.07 |
1.01 |
6.08 |
7% |
0.35 |
5.42 |
1.08 |
6.5 |
20% |
1.01 |
6.43 |
1.29 |
7.72 |
Протокол 191/29.09.2016 |
НСР-5962/01.04.2015. |
16.04.2015 |
02.11.2016 |
Неактивен |
3785 |
| Salbutamol |
20010556 |
Ecosal Easi-Breathe, Pressurised inhalation, suspension, 0,1 mg/dose - 200 doses, mg, Pack: 1 |
Teva Czech Industries s.r.o., Чешка република |
Czech Republiс; Norton Waterford (IVAX Pharmaceuticals Ireland) - Ireland |
5.07 |
1.01 |
6.08 |
7% |
0.35 |
5.42 |
1.08 |
6.5 |
20% |
1.01 |
6.43 |
1.29 |
7.72 |
|
НСР-5962/01.04.2015. |
16.04.2015 |
16.04.2015 |
Неактивен |
3785 |
| Salbutamol |
20010556 |
Ecosal Easi-Breathe, Pressurised inhalation, suspension, 0,1 mg/dose - 200 doses, mg, Pack: 1 |
Teva Czech Industries s.r.o., Чешка република |
Czech Republi; Norton Waterford (IVAX Pharmaceuticals Ireland) - Ireland |
5.1 |
1.02 |
6.12 |
7% |
0.36 |
5.46 |
1.09 |
6.55 |
20% |
1.02 |
6.48 |
1.3 |
7.78 |
|
НСР-2631/03.02.2014 |
20.02.2014 |
20.02.2014 |
Неактивен |
3785 |
| Salbutamol |
№ 121/ 09.12.2010; КЦРР-1199/13.08.2012 г. |
Ecosal Easi-Breathe, Pressurised inhalation, suspension, 0,1 mg/dose - 200 doses, mg, Pack: 1 |
Teva Czech Industries s.r.o., Чешка република |
Czech Republi; Norton Waterford (IVAX Pharmaceuticals Ireland) - Ireland |
5.42 |
1.08 |
6.5 |
7% |
0.38 |
5.8 |
1.16 |
6.96 |
20% |
1.08 |
6.88 |
1.38 |
8.26 |
|
НСР-70/07.06.2013 |
26.06.2013 |
26.06.2013 |
Неактивен |
3785 |
| Salbutamol |
6618/11.01.2010 |
Ecosal Easi-Breathe, Pressurised inhalation, suspension, 0,1 mg/dose - 200 doses, mg, Pack: 1 |
Teva Czech Industries s.r.o., Чешка република |
Teva Czech Industries s.r.o., Czech Republic; Norton Waterford (IVAX Pharmaceuticals Ireland) - Ireland |
6.83 |
1.37 |
8.2 |
7% |
0.48 |
7.31 |
1.46 |
8.77 |
20% |
1.37 |
8.68 |
1.74 |
10.42 |
|
КЦРР-1199/13.08.2012 |
28.08.2012 |
28.08.2012 |
Неактивен |
3785 |
| Salbutamol |
6618/11.01.2010 |
Ecosal Easi-Breathe, Pressurised inhalation, suspension, 0,1 mg/dose - 200 doses, mg, Pack: 1 |
Teva Czech Industries s.r.o., Чешка република |
Teva Czech Industries s.r.o., Czech Republic; Norton Waterford (IVAX Pharmaceuticals Ireland) - Ireland |
11.58 |
2.32 |
13.9 |
8% |
0.93 |
12.51 |
2.5 |
15.01 |
20% |
2.32 |
14.83 |
2.97 |
17.8 |
КЦ-1660/25.06.2010 промяна на обстоятелства |
КЦ-700/09.03.2009 |
24.03.2009 |
24.03.2009 |
Неактивен |
3785 |
| Salbutamol |
20010555 |
Ecosal Inhaler, Pressurised inhalation, suspension, 0,1 mg/dose - 200 doses, mg, Pack: 1 |
Teva B.V., Нидерландия |
Norton Waterford (IVAX Pharmaceuticals Ireland) - Ireland |
4.6 |
0.92 |
5.52 |
7% |
0.32 |
4.92 |
0.98 |
5.9 |
20% |
0.92 |
5.84 |
1.17 |
7.01 |
КЦ-1660/25.06.2010 промяна на обстоятелства; НСР-6128/29.04.2015; промяна на обстоятелства НСР-12608/05.05.2017 г.; НСР-17173/09.11.2018 |
КЦ-700/09.03.2009 |
24.03.2009 |
02.12.2018 |
Активен |
663 |
| Salbutamol |
20010555 |
Ecosal Inhaler, Pressurised inhalation, suspension, 0,1 mg/dose - 200 doses, mg, Pack: 1 |
Teva Czech Industries s.r.o., Чешка република |
Norton Waterford (IVAX Pharmaceuticals Ireland) - Ireland |
4.6 |
0.92 |
5.52 |
7% |
0.32 |
4.92 |
0.98 |
5.9 |
20% |
0.92 |
5.84 |
1.17 |
7.01 |
КЦ-1660/25.06.2010 промяна на обстоятелства; НСР-6128/29.04.2015; промяна на обстоятелства НСР-12608/05.05.2017 г. |
КЦ-700/09.03.2009 |
24.03.2009 |
02.06.2017 |
Неактивен |
663 |
| Salbutamol |
20010555 |
Ecosal Inhaler, Pressurised inhalation, suspension, 0,1 mg/dose - 200 doses, mg, Pack: 1 |
Teva Czech Industries s.r.o., Чешка република |
Teva Czech Industries s.r.o., Czech Republic; Norton Waterford (IVAX Pharmaceuticals Ireland) - Ireland |
4.6 |
0.92 |
5.52 |
7% |
0.32 |
4.92 |
0.98 |
5.9 |
20% |
0.92 |
5.84 |
1.17 |
7.01 |
КЦ-1660/25.06.2010 промяна на обстоятелства; НСР-6128/29.04.2015 |
КЦ-700/09.03.2009 |
24.03.2009 |
24.03.2009 |
Неактивен |
663 |
| Gliclazide |
20120076 |
Ecozid SR, Prolonged release tablet, 30, mg, Pack: 60 |
Екофарм Груп АД, България |
Екофарм ЕООД |
5.8 |
1.16 |
6.96 |
7% |
0.41 |
6.21 |
1.24 |
7.45 |
20% |
1.16 |
7.37 |
1.47 |
8.84 |
промяна на обстоятелства решение КЦPP-1699/27.11.2012 |
КЦРР-1295/21.08.2012; НСР-17061/26.10.2018 |
10.11.2018 |
02.12.2018 |
Активен |
1355 |
| Gliclazide |
20120076 |
Ecozid SR, Prolonged release tablet, 30, mg, Pack: 60 |
Екофарм Груп АД, България |
Екофарм ЕООД |
5.67 |
1.13 |
6.8 |
7% |
0.4 |
6.07 |
1.21 |
7.28 |
20% |
1.13 |
7.2 |
1.44 |
8.64 |
промяна на обстоятелства решение КЦPP-1699/27.11.2012 |
КЦРР-1295/21.08.2012 |
11.09.2012 |
11.09.2012 |
Неактивен |
1355 |
| Gliclazide |
20120076 |
Ecozid SR, Prolonged release tablet, 30, mg, Pack: 60 |
Екофарм Груп АД, България |
Екофарм ЕООД |
5.67 |
1.13 |
6.8 |
7% |
0.4 |
6.07 |
1.21 |
7.28 |
20% |
1.13 |
7.2 |
1.44 |
8.64 |
промяна на обстоятелства решение КЦPP-1699/27.11.2012 |
КЦРР-1295/21.08.2012 |
11.09.2012 |
11.09.2012 |
Неактивен |
1355 |
| Vancomycin |
ІІ-14746/08.11.2006 г. |
Edicin, Powder for solution for infusion, 1 g, mg, Pack: 1 |
Lek Pharmaceuticals d.d., Словения |
Lek Pharmaceuticals d.d., Slovenia |
19.11 |
3.82 |
22.93 |
6% |
1.15 |
20.26 |
4.05 |
24.31 |
18% |
3.44 |
23.7 |
4.74 |
28.44 |
|
НСР-1944/06.12.2013; НСР-10087/18.08.2016 |
24.12.2013 |
02.10.2016 |
Заличен |
2342 |
| Vancomycin |
ІІ-14746/08.11.2006 г. |
Edicin, Powder for solution for infusion, 1 g, mg, Pack: 1 |
Lek Pharmaceuticals d.d., Словения |
Lek Pharmaceuticals d.d., Slovenia |
19.11 |
3.82 |
22.93 |
6% |
1.15 |
20.26 |
4.05 |
24.31 |
18% |
3.44 |
23.7 |
4.74 |
28.44 |
|
НСР-1944/06.12.2013 |
24.12.2013 |
24.12.2013 |
Неактивен |
2342 |
| Vancomycin |
ІІ-14746/08.11.2006 г. |
Edicin, Powder for solution for infusion, 1 g, mg, Pack: 1 |
Lek Pharmaceuticals d.d., Словения |
Lek Pharmaceuticals d.d., Slovenia |
22.86 |
4.57 |
27.43 |
6% |
1.37 |
24.23 |
4.85 |
29.08 |
18% |
4.11 |
28.34 |
5.67 |
34.01 |
|
КЦ-527/13.02.2009 |
02.03.2009 |
02.03.2009 |
Неактивен |
2342 |
| Reboxetine |
990065 |
Edronax, Tablet, 4, mg, Pack: 60 |
Pfizer Europe MA EEIG, Белгия |
Pfizer Italia S.r.l., Италия |
31.33 |
6.27 |
37.6 |
4% |
1.25 |
32.58 |
6.52 |
39.1 |
16% |
5.01 |
37.59 |
7.52 |
45.11 |
Протокол 140/22.10.2015; Промяна на обстоятелствата НСР-17315/22.11.2018 |
КЦ-707/09.03.2009; НСР-20812/13.02.2020 |
28.02.2020 |
02.03.2020 |
Активен |
658 |
| Reboxetine |
990065/22.06.2006 г. |
Edronax, Tablet, 4, mg, Pack: 60 |
Pfizer Europe MA EEIG, Белгия |
Pfizer Italia S.r.l., Italy |
19.85 |
3.97 |
23.82 |
6% |
1.19 |
21.04 |
4.21 |
25.25 |
18% |
3.57 |
24.61 |
4.92 |
29.53 |
Протокол 140/22.10.2015; Промяна на обстоятелствата НСР-17315/22.11.2018 |
КЦ-707/09.03.2009 |
25.03.2009 |
02.01.2019 |
Неактивен |
658 |
| Reboxetine |
990065/22.06.2006 г. |
Edronax, Tablet, 4, mg, Pack: 60 |
Pfizer Europe MA EEIG, Обединено Кралство |
Pfizer Italia S.r.l., Italy |
19.85 |
3.97 |
23.82 |
6% |
1.19 |
21.04 |
4.21 |
25.25 |
18% |
3.57 |
24.61 |
4.92 |
29.53 |
Протокол 140/22.10.2015 |
КЦ-707/09.03.2009 |
25.03.2009 |
25.03.2009 |
Неактивен |
658 |
| Reboxetine |
0066/22.06.2007 г. |
Edronax, Tablet, 4, mg, Pack: 20 |
Pfizer Europe MA EEIG, Обединено Кралство |
Pfizer Italia S.r.l., Italy |
13.12 |
2.62 |
15.74 |
6% |
0.79 |
13.91 |
2.78 |
16.69 |
18% |
2.36 |
16.27 |
3.25 |
19.52 |
Цената се заличава с решение НСР-2231/20.12.2013 |
КЦРР-1071/26.07.2012 |
12.09.2012 |
12.09.2012 |
Заличен |
1357 |
| Reboxetine |
0066/22.06.2007 г. |
Edronax, Tablet, 4, mg, Pack: 20 |
Pfizer Europe MA EEIG, Обединено Кралство |
Pfizer Italia S.r.l., Italy |
14.08 |
2.82 |
16.9 |
6% |
0.84 |
14.92 |
2.98 |
17.9 |
18% |
2.53 |
17.45 |
3.49 |
20.94 |
|
КЦ-707/09.03.2009 |
25.03.2009 |
25.03.2009 |
Неактивен |
1357 |
| Rilpivirine |
EU/1/11/736/001 |
EDURANT, Film coated tablet, 25, mg, Pack: 30 |
Janssen-Cilag International N.V., Белгия |
Janssen-Cilag SpA Via C. Janssen IT-04010 Borgo San Michele Latina Italy |
395.57 |
79.11 |
474.68 |
4% |
10 |
405.57 |
81.11 |
486.68 |
16% |
25 |
430.57 |
86.11 |
516.68 |
|
НСР-7784/28.12.2015; HCP-10174/31.08.2016; НСР-12821/26.05.2017 г. |
10.06.2017 |
02.07.2017 |
Активен |
3344 |